HARRISBURG (October 4, 2018) – A new law designed to improve access to clinical trials for Pennsylvanians battling cancer is heading to the governor’s desk, state Senator Andy Dinniman said today.

House Bill 126 unanimously passed the Pennsylvania Senate this week after receiving unanimous approval in the House earlier this year. The bill was amended to include language from Dinniman’s Senate Bill 576, which clarifies what are considered inducements for patients to participate in cancer clinical trials.

“While there’s been some progress at both the state and federal levels in enacting ‘right to try’ laws for terminally ill patients, many families still struggle to access clinical trials due to the excessive costs associated with them, which can include everything from transportation to childcare to lodging during one’s treatment,” Dinniman said.

A national study in 2015 found that patient households making less than $50,000 annually were almost 30 percent less likely to participate in clinical trials. This disparity threatens one of the most basic ethical underpinnings of clinical research, the requirements that the benefits of research be made available equitably among all eligible individuals.

Meanwhile, some corporations, individuals, public and private foundations, health care providers, and other stakeholders are hesitant to contribute to, or accept funds from, programs that are organized to alleviate financial burdens faced by patients who wish to participate in clinical trials and their caregivers, due to concerns that the FDA and or other federal regulators would view the payments made from those funds as prohibited inducements for patients to receive the health care services provided during clinical trials.

House Bill 126 clarifies the difference between what is considered “inducement” (paying a person money including a lump sum or salary payment) for a patient to participate in a cancer clinical trial and the reimbursement of expenses for participating in a clinical trial. 

“This legislation makes it clear that such funds are reimbursements to assist patients with the costs associated with clinical trials rather than payments to encourage their participation,” Dinniman said. “It’s my hope that it will both help more patients access the funds and resources need to participate in potentially life-saving clinical trials and advance groundbreaking cancer research by broadening the scope of participation in such trials.”

Dinniman also credited Lt. Governor Mike Stack, who spearheaded the effort to pass such legislation in his previous role as a state Senator, as well as the Lazarex Cancer Foundation, which provides assistance with the costs of clinical trial participation.

House Bill 126 also permits entities such as summer camps, colleges and universities, restaurants, amusement parks, sport facilities, daycares and other facilities to have non-patient specific epinephrine auto-injectors in their facilities in case of emergency situations. 


Upcoming Events

July 2019
Sunday Monday Tuesday Wednesday Thursday Friday Saturday
June 30, 2019 July 1, 2019 July 2, 2019 July 3, 2019 July 4, 2019 July 5, 2019 July 6, 2019
July 7, 2019 July 8, 2019 July 9, 2019 July 10, 2019 July 11, 2019 July 12, 2019 July 13, 2019
July 14, 2019 July 15, 2019 July 16, 2019 July 17, 2019 July 18, 2019 July 19, 2019 July 20, 2019
July 21, 2019 July 22, 2019 July 23, 2019 July 24, 2019 July 25, 2019 July 26, 2019 July 27, 2019
July 28, 2019 July 29, 2019 July 30, 2019 July 31, 2019 August 1, 2019 August 2, 2019 August 3, 2019

Looking For Something

Still not finding what you're looking for? Please contact me or my staff so we can help you!